Back to news

EPAM climbs as investors continue to react to strong Q3 results and a larger buyback

Investivoq PriceTracker

EPAM Systems (EPAM) is up 4.7% today. Here is some analysis on what might have caused this price movement. ([investors.epam.com](https://investors.epam.com/overview/default.aspx?utm_source=openai))

Analysis: The most likely driver is continued follow-through from EPAM’s November 5 third-quarter release, which showed better profitability, modest revenue growth, and a higher full-year outlook. The stock also appears to be benefiting from EPAM’s enlarged repurchase plan and planned accelerated buyback, which can support sentiment by signaling confidence and reducing share count over time. ([investors.epam.com](https://investors.epam.com/news/news-details/2026/EPAM-Reports-Results-for-Third-Quarter-2026/default.aspx))

Details:

  • Third-quarter revenue grew 2.3% year over year, while organic constant-currency growth was 2.5%, suggesting the business returned to modest expansion. ([investors.epam.com](https://investors.epam.com/news/news-details/2026/EPAM-Reports-Results-for-Third-Quarter-2026/default.aspx))
  • GAAP diluted EPS rose to $2.53 from $1.91 a year earlier, and non-GAAP operating margin improved to 16.7% from 16.0%. ([investors.epam.com](https://investors.epam.com/news/news-details/2026/EPAM-Reports-Results-for-Third-Quarter-2026/default.aspx))
  • EPAM raised its full-year 2026 outlook to 3.5% to 3.7% revenue growth and projected non-GAAP diluted EPS of $13.23 to $13.31. ([investors.epam.com](https://investors.epam.com/news/news-details/2026/EPAM-Reports-Results-for-Third-Quarter-2026/default.aspx))
  • The board replaced the prior authorization with a new repurchase program of up to $1.8 billion, and EPAM said it expects to enter a $500 million accelerated share repurchase during the week of November 9. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1352010/000135201026000048/epam-20261104.htm))

    • Sources:

    EPAM Systems Investor Relations, SEC, Yahoo Finance

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    EARLY ACCESS
    Receive EPAM Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $EPAM Hedge Fund Activity

    We have seen 236 institutional investors add shares of $EPAM stock to their portfolio, and 334 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • BLACKROCK, INC. added 2,548,891 shares (+62.3%) to their portfolio in Q2 2026, for an estimated $202,254,500
    • BOSTON PARTNERS removed 2,076,668 shares (-98.4%) from their portfolio in Q2 2026, for an estimated $164,783,605
    • CAPITAL WORLD INVESTORS removed 2,015,102 shares (-29.5%) from their portfolio in Q2 2026, for an estimated $159,898,343
    • INVESCO LTD. removed 1,967,927 shares (-44.9%) from their portfolio in Q2 2026, for an estimated $156,155,007
    • AMERIPRISE FINANCIAL INC added 1,676,208 shares (+44.3%) to their portfolio in Q2 2026, for an estimated $133,007,104
    • BAILLIE GIFFORD & CO removed 1,193,056 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $94,668,993
    • MILLENNIUM MANAGEMENT LLC added 946,345 shares (+4811.1%) to their portfolio in Q2 2026, for an estimated $75,092,475

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $EPAM Price Targets

    Multiple analysts have issued price targets for $EPAM recently. We have seen 3 analysts offer price targets for $EPAM in the last 6 months, with a median target of $110.0.

    Here are some recent targets:

    • Bryan Bergin from TD Cowen set a target price of $131.0 on 07/09/2026
    • Steven Wahrhaftig from Wedbush set a target price of $99.0 on 06/15/2026
    • Surinder Thind from Jefferies set a target price of $110.0 on 05/29/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.